Dermapharm Holding SE Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	203.41	121.31	158.72	151.02	161.41
Short-Term Investments	1.06	0.59	0.82	1.48	1.76
Cash & Short-Term Investments	204.46	121.9	159.54	152.5	163.18
Cash Growth	67.74%	-23.60%	4.62%	-6.54%	32.85%
Accounts Receivable	110.66	102.18	95.41	96.72	72.52
Other Receivables	10.78	11.25	40.39	8.41	14.29
Receivables	121.44	113.43	135.8	105.13	86.81
Inventory	328.71	343.38	320.76	255.72	243.6
Prepaid Expenses	41.91	7.6	7.94	7	13.19
Other Current Assets	6.4	7.19	6.45	13.6	12.45
Total Current Assets	702.93	593.5	630.5	533.95	519.22
Property, Plant & Equipment	318.54	315.03	330.77	225.67	222.29
Long-Term Investments	33.67	21.87	25.06	36.57	105.62
Goodwill	587.06	576.38	578.52	271.32	264.73
Other Intangible Assets	379.09	406.14	441.61	212.12	217.13
Long-Term Deferred Charges	101.35	106.18	103.25	92.92	77.72
Other Long-Term Assets	0.92	0.94	0.97	0.28	0.27
Total Assets	2,187	2,080	2,161	1,413	1,407
Accounts Payable	96.26	94.79	86.64	56.1	52.1
Accrued Expenses	65.38	67.69	94.35	54.51	45.17
Short-Term Debt	0.02	0.04	0.01	0	-
Current Portion of Long-Term Debt	128.14	86.04	111.43	1.87	2.38
Current Portion of Leases	6.86	5.12	5	3.02	3.2
Current Income Taxes Payable	28.98	58.83	81.82	96.35	48.8
Current Unearned Revenue	1.71	1.5	1.43	0.56	0.62
Other Current Liabilities	15.58	12.91	13.82	5.38	3.35
Total Current Liabilities	342.93	326.92	394.49	217.79	155.61
Long-Term Debt	904.09	886.71	963.89	501.84	565.71
Long-Term Leases	18.82	12.35	13.25	9.72	9.01
Long-Term Unearned Revenue	11.06	11.34	11.69	9.2	9.46
Pension & Post-Retirement Benefits	111.08	119.63	117.22	89.28	128.88
Long-Term Deferred Tax Liabilities	105.07	111.7	112.39	50.52	36.06
Other Long-Term Liabilities	3	3.08	2.71	1.99	2.41
Total Liabilities	1,496	1,472	1,616	880.34	907.14
Common Stock	53.84	53.84	53.84	53.84	53.84
Retained Earnings	515.91	433.19	367.22	355.36	337.95
Comprehensive Income & Other	124.62	117.39	118.14	122.4	105.52
Total Common Equity	694.38	604.42	539.21	531.59	497.32
Minority Interest	-3.61	3.87	5.84	0.9	2.52
Shareholders' Equity	690.77	608.3	545.05	532.49	499.83
Total Liabilities & Equity	2,187	2,080	2,161	1,413	1,407
Total Debt	1,058	990.26	1,094	516.45	580.3
Net Cash (Debt)	-853.46	-868.36	-934.03	-363.95	-417.13
Net Cash Per Share	-15.85	-16.13	-17.35	-6.76	-7.75
Filing Date Shares Outstanding	53.84	53.84	53.84	53.84	53.84
Total Common Shares Outstanding	53.84	53.84	53.84	53.84	53.84
Working Capital	360	266.58	236.01	316.16	363.61
Book Value Per Share	12.90	11.23	10.01	9.87	9.24
Tangible Book Value	-271.77	-378.1	-480.92	48.15	15.46
Tangible Book Value Per Share	-5.05	-7.02	-8.93	0.89	0.29
Land	258.71	247.87	252.54	171.75	163.41
Machinery	279.01	252.92	234.8	178.45	163.77

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.